PTEN-deficient CRC cells with wildtype p21 re-expression remained sensitive to BETi, while p21 (T145D) re-expressing cells were strongly resistant to BETi (Fig. 6D, E). This evidence concerns the gene PTEN and colorectal carcinoma.